These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 19887623)

  • 1. Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 oncogene in endometrial cancer.
    Huang YW; Liu JC; Deatherage DE; Luo J; Mutch DG; Goodfellow PJ; Miller DS; Huang TH
    Cancer Res; 2009 Dec; 69(23):9038-46. PubMed ID: 19887623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypermethylation of miR-203 in endometrial carcinomas.
    Huang YW; Kuo CT; Chen JH; Goodfellow PJ; Huang TH; Rader JS; Uyar DS
    Gynecol Oncol; 2014 May; 133(2):340-5. PubMed ID: 24530564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOX11 hypermethylation as a tumor biomarker in endometrial cancer.
    Shan T; Uyar DS; Wang LS; Mutch DG; Huang TH; Rader JS; Sheng X; Huang YW
    Biochimie; 2019 Jul; 162():8-14. PubMed ID: 30935961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent hypermethylation of MLH1 promoter in normal endometrium of patients with endometrial cancers.
    Kanaya T; Kyo S; Maida Y; Yatabe N; Tanaka M; Nakamura M; Inoue M
    Oncogene; 2003 Apr; 22(15):2352-60. PubMed ID: 12700670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-129-2 suppresses proliferation and migration of esophageal carcinoma cells through downregulation of SOX4 expression.
    Kang M; Li Y; Liu W; Wang R; Tang A; Hao H; Liu Z; Ou H
    Int J Mol Med; 2013 Jul; 32(1):51-8. PubMed ID: 23677061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 in gastric cancer.
    Shen R; Pan S; Qi S; Lin X; Cheng S
    Biochem Biophys Res Commun; 2010 Apr; 394(4):1047-52. PubMed ID: 20331975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsatellite instability and epigenetic inactivation of MLH1 and outcome of patients with endometrial carcinomas of the endometrioid type.
    Zighelboim I; Goodfellow PJ; Gao F; Gibb RK; Powell MA; Rader JS; Mutch DG
    J Clin Oncol; 2007 May; 25(15):2042-8. PubMed ID: 17513808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOX4 interacts with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal cancer cells.
    Koumangoye RB; Andl T; Taubenslag KJ; Zilberman ST; Taylor CJ; Loomans HA; Andl CD
    Mol Cancer; 2015 Feb; 14():24. PubMed ID: 25644061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of miR-145 and miR-143 might be associated with DNA methyltransferase 3B overexpression and worse prognosis in endometrioid carcinomas.
    Zhang X; Dong Y; Ti H; Zhao J; Wang Y; Li T; Zhang B
    Hum Pathol; 2013 Nov; 44(11):2571-80. PubMed ID: 24071015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-195 inhibits migration, invasion and epithelial-mesenchymal transition (EMT) of endometrial carcinoma cells by targeting SOX4.
    Zhao X; Dai L; Yue Q; Wang H; Wang XU; Li Y; Chen R
    J Biosci; 2019 Dec; 44(6):. PubMed ID: 31894127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable MLH1 promoter methylation patterns in endometrial carcinomas of endometrioid subtype lacking DNA mismatch repair.
    Helmle KE; Otto CJ; Constantinescu G; Honore LH; Andrew SE
    Int J Gynecol Cancer; 2005; 15(6):1089-96. PubMed ID: 16343186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide DNA methylation sequencing reveals miR-663a is a novel epimutation candidate in CIMP-high endometrial cancer.
    Yanokura M; Banno K; Adachi M; Aoki D; Abe K
    Int J Oncol; 2017 Jun; 50(6):1934-1946. PubMed ID: 28440489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of endometrial cancer: a correlative study assessing microsatellite instability, MLH1 hypermethylation, DNA mismatch repair protein expression, and PTEN, PIK3CA, KRAS, and BRAF mutation analysis.
    Peterson LM; Kipp BR; Halling KC; Kerr SE; Smith DI; Distad TJ; Clayton AC; Medeiros F
    Int J Gynecol Pathol; 2012 May; 31(3):195-205. PubMed ID: 22498935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-137 is a tumor suppressor in endometrial cancer and is repressed by DNA hypermethylation.
    Zhang W; Chen JH; Shan T; Aguilera-Barrantes I; Wang LS; Huang TH; Rader JS; Sheng X; Huang YW
    Lab Invest; 2018 Nov; 98(11):1397-1407. PubMed ID: 29955087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Universal endometrial cancer tumor typing: How much has immunohistochemistry, microsatellite instability, and MLH1 methylation improved the diagnosis of Lynch syndrome across the population?
    Kahn RM; Gordhandas S; Maddy BP; Baltich Nelson B; Askin G; Christos PJ; Caputo TA; Chapman-Davis E; Holcomb K; Frey MK
    Cancer; 2019 Sep; 125(18):3172-3183. PubMed ID: 31150123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCNE1 amplification is associated with aggressive potential in endometrioid endometrial carcinomas.
    Nakayama K; Rahman MT; Rahman M; Nakamura K; Ishikawa M; Katagiri H; Sato E; Ishibashi T; Iida K; Ishikawa N; Kyo S
    Int J Oncol; 2016 Feb; 48(2):506-16. PubMed ID: 26647729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas.
    Esteller M; Levine R; Baylin SB; Ellenson LH; Herman JG
    Oncogene; 1998 Nov; 17(18):2413-7. PubMed ID: 9811473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for heritable predisposition to epigenetic silencing of MLH1.
    Chen H; Taylor NP; Sotamaa KM; Mutch DG; Powell MA; Schmidt AP; Feng S; Hampel HL; de la Chapelle A; Goodfellow PJ
    Int J Cancer; 2007 Apr; 120(8):1684-8. PubMed ID: 17230510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer.
    Tsuruta T; Kozaki K; Uesugi A; Furuta M; Hirasawa A; Imoto I; Susumu N; Aoki D; Inazawa J
    Cancer Res; 2011 Oct; 71(20):6450-62. PubMed ID: 21868754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sox4 functions as a positive regulator of β-catenin signaling through upregulation of TCF4 during morular differentiation of endometrial carcinomas.
    Saegusa M; Hashimura M; Kuwata T
    Lab Invest; 2012 Apr; 92(4):511-21. PubMed ID: 22231735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.